Skip to main content

Advertisement

Table 4 Clinical features of SCC transformation in MCTO

From: Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review

  Results
Age, years (n = 434)a 53.5 (13.9, 19–87)
<45 years 121
≥45 years 313
Tumor size, cm (n = 316)a 14.8 (5.9, 3.5–40)
Preoperative tumor markersb
SCC-Ag, ng/mL (n = 78) 7.4 (3.0, 20.0)
CA125, U/mL(n = 104) 64.4 (34.2, 143.0)
CA19–9,U/mL (n = 65) 144.0 (45.1, 943.5)
CEA, ng/mL (n = 51) 6.9 (2.5, 23.0)
Clinical manifestation (n = 204)
Abdominal/pelvic pain 139
Mass 53
Abdominal bloating 49
Physical examination 10
Urinary frequency 6
Weight loss 11
Change in bowel habits 20
Fever 7
FIGO staging (n = 414)
I 207
II 78
III 111
IV 18
Histological grade (n = 203)
1 54
2 84
3 65
  1. aMean (SD, range); b Median (Q25, Q75)